RE-BVS – Piemonte Repository

Sfoglia per AUTORE
COSSU MV
Collezione ASL Città di Torino

Items : 9

Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2024 May 2;79(5):1126-1132. doi: 10.1093/jac/dkae080.

2024
ASL Città di Torino

Cossu MV; Cattaneo D; Moschese D; Giacomelli A; Soloperto S; D'Avolio A; Antinori S; Gori A; Rizzardini G; Gervasoni C;

Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 May 2;68(5):e0017524. doi: 10.1128/aac.00175-24. Epub 2024 Mar 27.

2024
ASL Città di Torino

Cossu MV; D'Avolio A; Gervasoni C; Giacomelli A; Cattaneo D; Moschese D;

Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. in The patient / Patient. 2020 Jun;13(3):375-387. doi: 10.1007/s40271-020-00413-y.

2020
ASL Città di Torino

Antinori A; Cossu MV; Menzaghi B; Sterrantino G; Squillace N; Di Cristo V; Cattelan A; Focà E; Castagna A; Orofino G; Valenti D; D'Ettore G; Aprea L; Ferrara S; Locatelli ME; Madeddu G; Pontali E; Scerbo P; Rossetti B; Uglietti A; Termini R; Rucci F; Gori A; Mancusi D;

Effectiveness of Switching to Darunavir/Cobicistat in Virologically Suppressed HIV-Positive Patients Receiving Ritonavir-Boosted Protease Inhibitor-Based Regimen: The "STORE" Study. in Journal of acquired immune deficiency syndromes (1999) / J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):290-294. doi: 10.1097/QAI.0000000000002331.

2020
ASL Città di Torino

Gori A; Antinori A; Vergori A; Cossu MV; Menzaghi B; Sterrantino G; Rusconi S; Cattelan AM; Castelli F; Gianotti N; Orofino G; Ripamonti D; Savinelli S; Manzillo E; Santantonio TA; Celesia BM; Cauda R; Maserati R; d'Arminio Monforte A; Stingone C; Bonora S; Uglietti A; Termini R; Rucci F; Mancusi D;

Correction to: Patient-Reported Outcomes in an Observational Cohort of HIV-1-Infected Adults on Darunavir/Cobicistat-Based Regimens: Beyond Viral Suppression. in The patient / Patient. 2020 Aug;13(4):469-470. doi: 10.1007/s40271-020-00425-8.

2020
ASL Città di Torino

Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio? in AIDS (London, England) / AIDS. 2018 May 15;32(8):1083-1084. doi: 10.1097/QAD.0000000000001784.

2018
ASL Città di Torino

Capetti AF; Orofino G; Paladini L; Sterrantino G; DiGiambenedetto S; De Socio GV; Cenderello G; Cossu MV; Rizzardini G;

Dolutegravir Plus Rilpivirine as a Switch Option in cART-Experienced Patients: 96-Week Data. in The Annals of pharmacotherapy / Ann Pharmacother. 2018 Aug;52(8):740-746. doi: 10.1177/1060028018761600. Epub 2018 Feb 26.

2018
ASL Città di Torino

Capetti AF; Cossu MV; Sterrantino G; Barbarini G; Di Giambenedetto S; De Socio GV; Orofino G; Di Biagio A; Celesia BM; Rusconi S; Argenteri B; Rizzardini G;

A dual regimen of ritonavir/darunavir plus dolutegravir for rescue or simplification of rescue therapy: 48 weeks' observational data. in BMC infectious diseases / BMC Infect Dis. 2017 Sep 30;17(1):658. doi: 10.1186/s12879-017-2755-4.

2017
ASL Città di Torino

Capetti AF; Cossu MV; Orofino G; Sterrantino G; Cenderello G; De Socio GV; Cattelan AM; Soria A; Rusconi S; Riccardi N; Baldin GM; Niero FP; Barbarini G; Rizzardini G;

Switch to Dolutegravir plus Rilpivirine Dual Therapy in cART-Experienced Subjects: An Observational Cohort. in PloS one / PLoS One. 2016 Oct 14;11(10):e0164753. doi: 10.1371/journal.pone.0164753. eCollection 2016.

2016
ASL Città di Torino

Capetti AF; Sterrantino G; Cossu MV; Orofino G; Barbarini G; De Socio GV; Di Giambenedetto S; Di Biagio A; Celesia BM; Argenteri B; Rizzardini G;